financetom
Business
financetom
/
Business
/
Wendy's Long-Term Outlook 'Unnecessarily Aggressive' Amid Depressed Valuation, Wedbush Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wendy's Long-Term Outlook 'Unnecessarily Aggressive' Amid Depressed Valuation, Wedbush Says
Mar 7, 2025 6:33 AM

09:05 AM EST, 03/07/2025 (MT Newswires) -- Wendy's (WEN) growth guidance through 2028 appears to be "unnecessarily aggressive" given the fast food chain's currently depressed valuation, Wedbush Securities said in a Friday client note.

The company on Thursday said it expects systemwide sales to rise between 5% and 6% annually over the long term and reach between $17.5 billion and $18 billion in 2028. It also projects net restaurant units to increase by 3% to 4% annually and reach between 8,100 and 8,300 by 2028.

Wendy's reiterated its full-year 2025 global systemwide sales growth outlook of 2% to 3%, which Wedbush expects to be driven by positive check and transaction gains. The current consensus on FactSet is for a same-store sales increase of 1.5%.

"I'm excited about our upcoming innovation and collaborations that will build on our high-quality menu with fresh ingredients as we continue to elevate our customer focus," Wendy's Chief Executive Kirk Tanner said Thursday. The company is investing in building new restaurants around the world and using technology to "increase restaurant profitability," according to Chief Financial Officer Ken Cook.

A more conservative long-term guidance would have been "prudent and palatable" given the company's discount to its own historical valuation and to franchised peers, Wedbush analyst Nick Setyan said. The company's renewed focus on core equities and improving operations such as customer service makes sense, but a lack of incremental emphasis on value could be a risk, the brokerage said.

"We came away incrementally more concerned that quarter-to-quarter comp volatility could become the new norm as management leans into collaborations without effectively addressing value and the continued (if not accelerating) pressure on the lower income customer," Setyan wrote in the note.

Wendy's continues to forecast adjusted earnings before interest, taxes, depreciation and amortization of $550 million to $560 million for the current year and is targeting annual growth of 7% to 8% for the metric in the long term. Wedbush views the 200-basis-point margin opportunity through productivity upgrades, menu mix management and labor optimization, among other factors, as the "most encouraging goal."

The brokerage maintained its neutral rating on Wendy's stock and reiterated the 12-month price target of $16.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cell therapy firm ProKidney's Q3 net loss narrows 
Cell therapy firm ProKidney's Q3 net loss narrows 
Nov 10, 2025
Overview * ProKidney ended Q3 2025 with $272 mln in cash, supporting operations into mid-2027 Outlook * Company expects cash to support operations into mid-2027 Result Drivers * R&D EXPENSES - Decrease in R&D expenses due to winding down of completed or terminated trials Key Details Metric Beat/Mis Actual Consensu s s Estimate Q3 $38.76 Operatin mln g Expenses Q3...
Theravance Biopharma marginally beats Q3 revenue estimates, YUPELRI sales up 15%
Theravance Biopharma marginally beats Q3 revenue estimates, YUPELRI sales up 15%
Nov 10, 2025
Overview * Theravance Q3 revenue slightly beats estimates, driven by Viatris collaboration * Adjusted net income for Q3 beats estimates, reflecting financial discipline * YUPELRI net sales in Q3 reach $71.4 mln, up 15% YoY Outlook * Theravance expects topline Phase 3 CYPRESS results in Q1 2026 * Company on track to achieve $50 mln TRELEGY sales milestone in 2025...
TechTarget Q3 revenue slightly beats estimates 
TechTarget Q3 revenue slightly beats estimates 
Nov 10, 2025
Overview * TechTarget ( TTGT ) Q3 revenue slightly beats analyst expectations, growing 1% year-on-year * Company reports Q3 net loss of $76.8 mln, impacted by non-cash impairment * Adjusted EBITDA for Q3 grows 9% year-on-year, reflecting operational progress Outlook * Company reaffirms 2025 full-year guidance for flat revenues and Adjusted EBITDA of $85 mln * Company expects operating momentum...
TeraWulf Q3 Loss Widens, Revenue Rises
TeraWulf Q3 Loss Widens, Revenue Rises
Nov 10, 2025
04:33 PM EST, 11/10/2025 (MT Newswires) -- TeraWulf ( WULF ) reported a Q3 loss late Monday of $1.13 per diluted share, widening from a loss of $0.06 a year earlier. Analysts surveyed by FactSet expected a loss of $0.04. Revenue for the three months ended Sept. 30 was $50.6 million, up from $27.1 million a year earlier. Analysts polled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved